You just read:

Blueprint Medicines Announces Data Presentations Highlighting Significant Progress in Advancing RET-Altered Cancer and Systemic Mastocytosis Programs

News provided by

Blueprint Medicines Corporation

May 14, 2020, 09:00 ET